Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,305.00    -15.00 (-0.65%)
Bid:
2,300.00
Ask:
2,305.00
Spread: 5.00 (0.217%)
Market Cap: £3.13b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

7 Feb 2023 07:00

RNS Number : 0825P
RIT Capital Partners PLC
07 February 2023
Β 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

7 February 2023

Β 

Β 

December 2022 Preliminary Unaudited Net Asset Value

Β 

The preliminary, unaudited, diluted net asset value of RIT Capital Partners plc (the Company) as at 31 December 2022 (with debt at fair value) was 2,388p per Β£1 ordinary share (30 November 2022: 2,454p).

This represented a decline of -2.7% for the month of December, outperforming the MSCI ACWI (50% Β£) which fell -5.0% in the month. The outperformance was driven by our quoted equity book, and positive contributions from both our absolute return & credit book as well as real assets. The NAV reflected the six-monthly revaluation of our direct private investments to 31 December 2022, and, as normal, the 30 September valuations from external managers for ~94% of our private funds (with around 6% at 31 December).

Β 

2022 Preliminary Unaudited Performance

Β 

Last year was one of the most challenging years for financial markets for more than a decade, with a multitude of issues causing almost all asset classes to decline during the year. The S&P 500, the NASDAQ and the FTSE 250 closed down -18%, -32% and -17% respectively. Government bonds provided no safe harbour, with long-term US and UK bonds losing -29% and -40% respectively. Our NAV was not immune from these pressures, with a preliminary, unaudited NAV per share total return (including dividends) of -13.3% compared to the ACWI of -12.9%. With inflation at multi-year highs, our inflation measure of CPI+3.0%, was 13.5% for the year.Β 

Key factors impacting our return for the year were:

-

Retaining one of our lowest quoted equity exposures in a decade, coupled with action we took within the quoted equity portfolio, helped limit the downside. Nevertheless, this book saw a negative contribution of around -6.7%;

-

Private investments detracted by -6.2% of NAV, split broadly equally across the directs and funds, giving back a portion of the ~+34% NAV contribution across 2020 and 2021;

-

Our absolute return and credit book held up reasonably well, albeit with some mixed performance from our macro managers;

-

Through our currency positioning, we ensured that much of our exposure was held outside the weakening sterling, resulting in a positive contribution for the year.

While any short-term decline in NAV is uncomfortable, our aims and objectives are long term. Over the last three years our NAV returned a preliminary ~25% against the ACWI at 17.7%. Similarly, our 5-year performance of around 41% compares favourably to the ACWI at 35.5%, and over 10-years our NAV (including dividends) has grown by approximately 140%.

As normal at this stage of our year end, the preliminary NAV is an estimate and remains subject to adjustment and audit. Full details will be included in the 2022 Annual Report & Accounts, which is expected to be published at the end of February.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NAVVQLFBXLLBBBQ
Date   Source Headline
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20254:59 pmRNSHolding(s) in Company
9th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 202510:53 amRNSTotal Voting Rights
1st Oct 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
22nd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 20257:00 amRNSTransaction in Own Shares
17th Sep 20257:00 amRNSTransaction in Own Shares
16th Sep 20257:00 amRNSNet Asset Value(s)
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
3rd Sep 20257:00 amRNSTransaction in Own Shares
1st Sep 202511:21 amRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
21st Aug 20256:27 pmRNSHolding(s) in Company
18th Aug 20257:00 amRNSNet Asset Value(s)
7th Aug 20257:25 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSHalf-year Report
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20259:47 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSNet Asset Value(s)
22nd Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
1st Jul 20254:25 pmRNSDirector/PDMR Shareholding
1st Jul 20254:19 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSTransaction in Own Shares
30th Jun 20255:13 pmRNSShare Buyback Management
30th Jun 20257:00 amRNSTransaction in Own Shares
27th Jun 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.